OSRH
Price
$0.49
Change
-$0.01 (-2.00%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
12.85M
Intraday BUY SELL Signals
SLXN
Price
$2.47
Change
-$0.10 (-3.89%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
8.04M
Intraday BUY SELL Signals
Interact to see
Advertisement

OSRH vs SLXN

Header iconOSRH vs SLXN Comparison
Open Charts OSRH vs SLXNBanner chart's image
OSR Holdings
Price$0.49
Change-$0.01 (-2.00%)
Volume$500
Capitalization12.85M
Silexion Therapeutics
Price$2.47
Change-$0.10 (-3.89%)
Volume$322
Capitalization8.04M
OSRH vs SLXN Comparison Chart in %
OSRH
Daily Signal:
Gain/Loss:
SLXN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
OSRH vs. SLXN commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OSRH is a Hold and SLXN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (OSRH: $0.50 vs. SLXN: $2.57)
Brand notoriety: OSRH and SLXN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: OSRH: 12% vs. SLXN: 12%
Market capitalization -- OSRH: $12.85M vs. SLXN: $8.04M
OSRH [@Biotechnology] is valued at $12.85M. SLXN’s [@Biotechnology] market capitalization is $8.04M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OSRH’s FA Score shows that 1 FA rating(s) are green whileSLXN’s FA Score has 1 green FA rating(s).

  • OSRH’s FA Score: 1 green, 4 red.
  • SLXN’s FA Score: 1 green, 4 red.
According to our system of comparison, SLXN is a better buy in the long-term than OSRH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OSRH’s TA Score shows that 2 TA indicator(s) are bullish while SLXN’s TA Score has 5 bullish TA indicator(s).

  • OSRH’s TA Score: 2 bullish, 7 bearish.
  • SLXN’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, SLXN is a better buy in the short-term than OSRH.

Price Growth

OSRH (@Biotechnology) experienced а -11.15% price change this week, while SLXN (@Biotechnology) price change was -8.54% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.28%. For the same industry, the average monthly price growth was -5.78%, and the average quarterly price growth was +64.80%.

Industries' Descriptions

@Biotechnology (-2.28% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OSRH($12.8M) has a higher market cap than SLXN($8.04M). SLXN (-91.476) and OSRH (-95.660) have similar YTD gains . OSRH has higher annual earnings (EBITDA): -12.05M vs. SLXN (-17.81M). SLXN has more cash in the bank: 3.47M vs. OSRH (1.58M). SLXN has less debt than OSRH: SLXN (3.7M) vs OSRH (4.3M). OSRH has higher revenues than SLXN: OSRH (105K) vs SLXN (0).
OSRHSLXNOSRH / SLXN
Capitalization12.8M8.04M159%
EBITDA-12.05M-17.81M68%
Gain YTD-95.660-91.476105%
P/E RatioN/A0.01-
Revenue105K0-
Total Cash1.58M3.47M46%
Total Debt4.3M3.7M116%
TECHNICAL ANALYSIS
Technical Analysis
OSRHSLXN
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
55%
Bullish Trend 3 days ago
47%
Momentum
ODDS (%)
Bearish Trend 2 days ago
27%
Bearish Trend 6 days ago
29%
MACD
ODDS (%)
Bearish Trend 2 days ago
14%
Bullish Trend 2 days ago
36%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
52%
Bearish Trend 2 days ago
48%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 2 days ago
58%
Advances
ODDS (%)
Bullish Trend 23 days ago
67%
Bullish Trend 8 days ago
54%
Declines
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 2 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
18%
Bullish Trend 2 days ago
50%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
67%
View a ticker or compare two or three
Interact to see
Advertisement
OSRH
Daily Signal:
Gain/Loss:
SLXN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FMFC0.690.06
+9.64%
Kandal M Venture Limited
ROL58.610.65
+1.12%
Rollins
PLMR129.501.02
+0.79%
Palomar Holdings
TXO13.33-0.05
-0.37%
TXO Partners LP
ELTX8.51-0.21
-2.41%
Elicio Therapeutics

OSRH and

Correlation & Price change

A.I.dvisor tells us that OSRH and MIST have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OSRH and MIST's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OSRH
1D Price
Change %
OSRH100%
+3.13%
MIST - OSRH
29%
Poorly correlated
+3.88%
EDSA - OSRH
23%
Poorly correlated
+0.29%
EDIT - OSRH
22%
Poorly correlated
+1.55%
LEXX - OSRH
22%
Poorly correlated
+3.47%
VERA - OSRH
21%
Poorly correlated
-2.00%
More